This can be clearly seen with hemoglobinopathy gene polymorphisms such as sickle cell, thalassemia or glucose-6-phosphate dehydrogenase (G6PD) [148,149,150,151,152] which offer resistance to infection of RBCs by Plasmodium and reduced clinical severity when infection does occur. This evidence concerns the gene G6PD and hemoglobinopathy.